ICAP
ABBV icon

Independence Capital Asset Partners’s AbbVie ABBV Stock Holding History

Independence Capital Asset Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-244,209
Closed -$14.1M – 72
2014
Q3 		$14.1M Buy
+244,209
New +$13.6M 1.97% 20

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Independence Capital Asset Partners's ABBV Position: Q4 2014 in Review

Independence Capital Asset Partners sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 244,209 shares — an estimated $14.1M sold.

Independence Capital Asset Partners first reported a position in ABBV in Q3 2014 and held it in 1 quarter. The position peaked at $14.1M in Q3 2014. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Independence Capital Asset Partners reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
  • Independence Capital Asset Partners sold 244,209 AbbVie shares in Q4 2014, an estimated $14.1M.
  • Independence Capital Asset Partners first reported a position in AbbVie in Q3 2014 and held it in 1 quarter.
  • Independence Capital Asset Partners's AbbVie position peaked at $14.1M in Q3 2014.
  • 1,604 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Independence Capital Asset Partners's 13F filing for Q4 2014, filed 13 Feb 2015.